<?xml version="1.0" encoding="UTF-8"?><REUTERS CGISPLIT="TRAINING-SET" LEWISSPLIT="TRAIN" NEWID="9844" OLDID="15365" TOPICS="YES">
<DATE>26-MAR-1987 09:17:18.80</DATE>
<TOPICS><D>acq</D></TOPICS>
<PLACES><D>usa</D></PLACES>
<PEOPLE/>
<ORGS/>
<EXCHANGES/>
<COMPANIES/>
<UNKNOWN> 
   F
   f0919 reute
r f BC-ETHYL-CORP-&lt;EY&gt;-UNITS   03-26 0078</UNKNOWN>
<TEXT> 
<TITLE>ETHYL CORP &lt;EY&gt; UNITS COMPLETE ACQUISITON</TITLE>
<DATELINE>    RICHMOND, Va., March 26 - </DATELINE><BODY>Ethyl Corp said its subsidiaries
completed the acquisiton of Nelson Research and Development Co
&lt;NELR&gt;.
    The merger was approved following completion on Jan 27 of a
tender offer valued at approximately 55 mln dlrs, the company
said.
    It added that Nelson, based in Irvine, Calif., will be
operated as a wholly-owned subsidiary of Ethyl.
    Nelson designs and develops new drugs, Ethyl said.
 Reuter
 </BODY></TEXT>
</REUTERS>